Insilico Medicine Email Format
Biotechnology ResearchMassachusetts, United States201-500 Employees
Insilico Medicine is a clinical-stage biotechnology company based in Cambridge, Massachusetts, operating in the biotechnology research sector. It employs artificial intelligence to integrate biology, chemistry, and clinical trial analysis, with AI platforms that use generative models, reinforcement learning, and transformer-based methods to identify targets and design novel molecules with specific properties. The company aims to discover and develop drugs across cancer, fibrosis, immune-related conditions, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-associated illnesses. The organization lists 201-500 employees and is headquartered at 1000 Massachusetts Avenue, Cambridge, MA 02138, United States. Insilico Medicine combines biology, chemistry, and clinical data within its AI-enabled research framework to advance drug discovery and development.